ArticleMovement disorders clinical practice2026
Prevalence of Parkinson's Disease in a Town of the Central Highlands of Peru: A Population-Based Study.
Article in Movement disorders clinical practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hoehn and Yahr Stage and Non-Motor Symptom Burden in Parkinson's Disease: A Cross-Sectional Study in Peru.Medicina (Kaunas, Lithuania) · 2026Article
- Bridging global diversity gaps in Parkinson disease research.Nature reviews. Neurology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundThe global prevalence of Parkinson's disease (PD) is estimated to be 315 per 100,000 inhabitants, with variations across regions and depending on the epidemiological methods used. Door-to-door prevalence studies in Andean communities are notably underrepresented in the literature.
objectiveThe aim of this study was to estimate the PD prevalence in Jauja.
methodsA cross-sectional community-based door-to-door prevalence study was conducted from April 2018 to September 2019. We used a Spanish version of the 9-item screening questionnaire (9-item SQ). Trained interviewers conducted face-to-face screening surveys. Participants presenting "suspected parkinsonism" underwent further neurological assessment. PD cases responded to the LARGE-PD questionnaire and "pesticide exposure questionnaire." We calculated the crude prevalence, gender- and age-specific rates, and age-adjusted rates.
resultsOut of 2527 eligible individuals, 1960 completed the screening survey. Of these, 563 were selected for neurological assessment, and 337 underwent neurological examination. PD was confirmed in 21 individuals, 16 of whom were identified using the 9-item SQ with a crude prevalence of 816/100,000. We observed higher rates of PD in older age groups and in males compared to females (1.6 vs. 0.3%, P < 0.05). The age-standardized prevalence was 566/100,000 (95% confidence interval [CI]: 496.6-635.2). Among PD cases, the most common environmental exposures were living near farming fields and pesticide exposure.
conclusionsThe observed prevalence of PD in this town in the central highlands of Peru aligns with previous reports, with notably higher rates among individuals over the age of 80. Further prospective studies are warranted to investigate the potential influence of environmental factors on PD prevalence in this region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.